Search Results - "Schultz CW"

Author Correction: ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer.

Authors: Schultz CW Zhang Y Elmeskini R et al.

Source: EMBO molecular medicine [EMBO Mol Med] 2024 Mar; Vol. 16 (3), pp. 664.

Publication Type: Published Erratum

Journal Info: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE; PubMed not MEDLINE

ASO Author Reflections: Margin-Positive Pancreatic Ductal Adenocarcinoma During Pancreaticoduodenectomy: Additional Resection Does Not Improve Survival.

Authors: Zheng R Nauheim D Bassig J et al.

Source: Annals of surgical oncology [Ann Surg Oncol] 2020 Dec; Vol. 27 (Suppl 3), pp. 895-896. Date of Electronic Publication: 2020 Aug 19.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

Stiffness-dependent alveolar type II cell senescence in idiopathic pulmonary fibrosis.

Authors: Lin CR Woranam K Hayek H et al.

Source: Cell communication and signaling : CCS [Cell Commun Signal] 2026 Apr 25; Vol. 24 (1). Date of Electronic Publication: 2026 Apr 25.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-811X (Electronic) Linking ISSN: 1478811X NLM ISO Abbreviation: Cell Commun Signal Subsets: MEDLINE; In Process

Lamin A/C loss promotes R-loop-mediated genomic instability and poor survival in small-cell lung cancer.

Authors: Schultz CW Saha S Dhall A et al.

Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2025 Oct 28; Vol. 122 (43), pp. e2503387122. Date of Electronic Publication: 2025 Oct 23.

Publication Type: Journal Article

Journal Info: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE

Integrated pan-cancer analysis of RNA binding protein HuR investigates its biomarker potential in prognosis, immunotherapy, and drug sensitivity.

Authors: Peng, Jian Quan, Jichuan Wang, Xiaoru

Source: PLoS Computational Biology. 8/25/2025, Vol. 21 Issue 8, p1-25. 25p.

Medicinal chemistry breakthroughs on ATM, ATR, and DNA-PK inhibitors as prospective cancer therapeutics.

Authors: Sharma, Ram Mishra, Anshul Bhardwaj, Monika et al.

Source: Journal of Enzyme Inhibition & Medicinal Chemistry. Dec2025, Vol. 40 Issue 1, p1-49. 49p.

SurvSig: Harnessing gene expression signatures to uncover heterogeneity in lung neuroendocrine neoplasms.

Authors: Nemes K Fűr GM Benő A et al.

Source: Computational and structural biotechnology journal [Comput Struct Biotechnol J] 2025 Jun 06; Vol. 27, pp. 2574-2583. Date of Electronic Publication: 2025 Jun 06 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology Country of Publication: Netherlands NLM ID: 101585369 Publication Model: eCollection Cited Medium: Print ISSN: 2001-0370 (Print) Linking ISSN: 20010370 NLM ISO Abbreviation: Comput Struct Biotechnol J Subsets: PubMed not MEDLINE

Lamin A/C Deficiency Drives Genomic Instability and Poor Survival in Small-Cell Lung Cancer through Increased R-loop Accumulation.

Authors: Schultz CW Saha S Dhall A et al.

Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 May 03. Date of Electronic Publication: 2025 May 03.

Publication Type: Journal Article; Preprint

Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancer.

Authors: Morris, Benjamin B. Heeke, Simon Xi, Yuanxin et al.

Source: Molecular Cancer. 3/20/2025, Vol. 24 Issue 1, p1-19. 19p.

Synthesis of the fluorescent polymer containing pyrene and its application in the detection of tea polyphenol.

Authors: Yi, Cuilian Xu, Chunyan Zhao, Xiaoyan et al.

Source: Polymer Engineering & Science; Mar2025, Vol. 65 Issue 3, p990-1002, 13p

Adipose-specific HuR deletion protects against high-fat diet-induced obesity in mice through upregulating Ucp1 expression.

Authors: Fan, Xiuqin Wang, Yuanyuan Li, Ping et al.

Source: Lipids in Health & Disease. 8/25/2025, Vol. 24 Issue 1, p1-13. 13p.

Spatially resolved analysis of TGF/BMP signalling in pancreatic ductal adenocarcinoma by digital pathology identifies patient subgroups with adverse outcome.

Authors: Bräutigam, Konstantin Zens, Philipp Reinhard, Stefan et al.

Source: BMC Cancer. 8/18/2025, Vol. 25 Issue 1, p1-15. 15p.

Characteristics of consecutive versus non-consecutive frequent emergency medical services transport to a single emergency department.

Authors: Kim, Sun Hyu Lee, Hyeji

Source: PLoS ONE. 5/9/2024, Vol. 19 Issue 5, p1-13. 13p.

CK1α agonists attenuate medulloblastoma stemness and relapse risk.

Authors: Peterson K Turos-Cabal M Shahani P et al.

Source: Cell death & disease [Cell Death Dis] 2026 Apr 24; Vol. 17 (1). Date of Electronic Publication: 2026 Apr 24.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE

肿瘤类器官在精准肺癌药物筛选中的研发与进展.

Alternate Title: Research, development and advance in precise screening of lung cancer drugs with tumor organoids.

Authors: 刘继伟 刘伟慈 毛文君

Source: Chinese Journal of Tissue Engineering Research / Zhongguo Zuzhi Gongcheng Yanjiu. 11/8/2024, Vol. 28 Issue 31, p5078-5084. 7p.

Asia‐inclusive drug development leveraging principles of ICH E5 and E17 guidelines: Case studies illustrating quantitative clinical pharmacology as a foundational enabler.

Authors: Lu, Hong Klopp‐Schulze, Lena Mukker, Jatinder Kaur et al.

Source: CTS: Clinical & Translational Science. Oct2024, Vol. 17 Issue 10, p1-11. 11p.

Genomic alterations and transcriptional phenotypes in circulating free DNA and matched metastatic tumor.

Authors: Takahashi N Pongor L Agrawal SP et al.

Source: Genome medicine [Genome Med] 2025 Feb 25; Vol. 17 (1), pp. 15. Date of Electronic Publication: 2025 Feb 25.

Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101475844 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-994X (Electronic) Linking ISSN: 1756994X NLM ISO Abbreviation: Genome Med Subsets: MEDLINE

Genomic signatures in plasma circulating tumor DNA reveal treatment response and prognostic insights in mantel cell lymphoma.

Authors: Ouyang, Zhou Zeng, Ruolan Wang, Song et al.

Source: Cancer Cell International. 5/3/2025, Vol. 25 Issue 1, p1-17. 17p.

CMSS1: A RNA binding protein with pivotal roles in non-small cell lung cancer progression and prognosis.

Authors: Fan, Zhe Liu, Wanyu Gao, Zhiwei et al.

Source: BMC Cancer. 4/14/2025, Vol. 25 Issue 1, p1-16. 16p.

전이성 췌장암에서 5년 생존한 환자 1예.

Alternate Title: A Case of Five-Year Survival in Metastatic Pancreatic Cancer.

Authors: Park, Hyun Jung Lee, Kwang Hyuck Lee, Jong Kyun et al.

Source: Korean Journal of Pancreas & Biliary Tract / Daehan Chwedamdo Haghoeji. Jul2024, Vol. 29 Issue 3, p110-114. 5p.